NQ Y15
Latest Information Update: 29 Apr 2002
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antithrombotics
- Mechanism of Action Thromboxane A2 receptor antagonists; Thromboxane A2 synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 22 Feb 1999 New profile
- 22 Feb 1999 Preclinical development for Thrombosis in South Korea (Unknown route)